23,283 Shares in Cabot Corporation $CBT Purchased by Jupiter Topco LLC

Key Points

• Jupiter Topco LLC acquired 23,283 Cabot shares worth approximately $2.1 million, while institutional investors collectively own 93.18% of CBT.
• Analysts maintain a generally cautious outlook, with an average “Hold” rating and an $89 price target; target prices range from $78 to $100.
• Cabot exceeded quarterly earnings and revenue expectations, reported 6.4% year-over-year revenue growth, and declared a quarterly dividend of $0.4725, equivalent to a 2.3% annual yield.

Jupiter Topco LLC acquired a new stake in shares of Cabot Corporation (NYSE:CBT - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 23,283 shares of the specialty chemicals company's stock, valued at approximately $2,116,000.

Several other large investors have also bought and sold shares of CBT. NewEdge Advisors LLC grew its holdings in shares of Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company's stock valued at $82,000 after buying an additional 947 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company's stock worth $36,802,000 after acquiring an additional 108,645 shares during the last quarter. Empowered Funds LLC lifted its position in Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company's stock valued at $2,341,000 after acquiring an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company's stock valued at $10,145,000 after purchasing an additional 4,048 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 364 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on CBT. Truist Financial set a $100.00 price target on Cabot in a research note on Wednesday, August 5th. Mizuho boosted their target price on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research report on Thursday, June 25th. JPMorgan Chase & Co. upped their target price on shares of Cabot from $70.00 to $78.00 and gave the company an "underweight" rating in a research note on Friday, August 7th. UBS Group dropped their price target on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a report on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Cabot has an average rating of "Hold" and an average target price of $89.00.

Insider Activity

In related news, CEO Sean Keohane sold 134,895 shares of the firm's stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares of the company's stock, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders have sold a total of 229,597 shares of company stock valued at $19,646,746 over the last quarter. Company insiders own 3.08% of the company's stock.

Cabot Stock Performance

Shares of CBT opened at $81.26 on Friday. The firm has a market capitalization of $4.19 billion, a P/E ratio of 22.89, a PEG ratio of 10.88 and a beta of 0.83. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53. The business has a fifty day moving average of $86.91 and a 200 day moving average of $81.40.

Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts' consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts anticipate that Cabot Corporation will post 6.35 EPS for the current year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot's dividend payout ratio is 53.24%.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source